Skip to content

Application of Transnasal Humidified High-Flow Therapy in Percutaneous Vertebroplasty for Elderly Patients

Comparison of High-Flow Nasal Cannula Therapy versus Endotracheal Intubation for Intraoperative Oxygenation in Elderly Patients Undergoing Vertebroplasty:A Randomized Controlled Non-Inferiority Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113693
Enrollment
Unknown
Registered
2025-12-02
Start date
2025-12-08
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spine Fracture

Interventions

High-Flow Nasal Cannula Group:High-Flow Nasal Cannula was used for oxygenation during the entire period of Total Intravenous Anesthesia.
Endotracheal Intubation Group:Oxygen was administered via endotracheal intubation with mechanical ventilation throughout Total Intravenous Anesthesia (TIVA).

Sponsors

Sir Run Run Hospital Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Age 65 years or older; 2.American Society of Anesthesiologists (ASA) Physical Status Classification of I, II, or III; 3.Body Mass Index (BMI) >=18 kg/m^2 and < 30 kg/m^2; 4.Scheduled to undergo Percutaneous Kyphoplasty (PKP) or Percutaneous Vertebroplasty (PVP) under Total Intravenous Anesthesia (TIVA).

Exclusion criteria

Exclusion criteria: 1.Severe systemic diseases (e.g., heart failure, ARDS); 2.Hemoglobin (Hb) level < 90 g/L; 3.Recent acute upper respiratory infection or pulmonary infection; 4.Nasal stenosis or deviated nasal septum; 5.Long-term use of benzodiazepines; 6.Anticipated difficult airway; 7.Chronic alcoholism; 8.Psychiatric disorders or communication difficulties; 9.History of allergy to the related anesthetic agents.

Design outcomes

Primary

MeasureTime frame
The lowest SpO2 value during anesthesia;

Secondary

MeasureTime frame
Incidence of Hypoxemia;Intraoperative MAP, HR, SpO2;(PHPaO2PaCO2PaO2/FiO2Lac);QoR-15 score;Emergence time; PACU length of stay; Operative time; Hospital length of stay; Time to first ambulation; Time to first flatus.;Intraoperative medication usage (dosages of remimazolam, remifentanil, vasoactive agents, etc.);Surgeon satisfaction score; Patient satisfaction score;

Countries

China

Contacts

Public ContactWang Liang

Sir Run Run Hospital Nanjing Medical University

wl49606@163.com+86 187 6182 0608

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026